text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 67330-25-0 | Product Number: B5391

Butyl 2-[[3-(Trifluoromethyl)phenyl]amino]benzoate


Purity: >98.0%(HPLC)(N)
Synonyms:
  • N-(3-Trifluoromethylphenyl)anthranilic Acid Butyl Ester
  • Butyl Flufenamate
  • Flufenamic Acid Butyl Ester
  • Butyl N-(3-Trifluoromethylphenyl)anthranilate
  • 2-[[3-(Trifluoromethyl)phenyl]amino]benzoic Acid Butyl Ester
  • Ufenamate
Product Documents:
200MG
88,00 €
2   4  
1G
282,00 €
Contact Us 6  

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number B5391
Purity / Analysis Method >98.0%(HPLC)(N)
Molecular Formula / Molecular Weight C__1__8H__1__8F__3NO__2 = 337.34 
Physical State (20 deg.C) Liquid
Storage Temperature Room Temperature (Recommended in a cool and dark place, <15°C)
Condition to Avoid Light Sensitive
CAS RN 67330-25-0
Reaxys Registry Number 2768727
PubChem Substance ID 354334451
Merck Index (14) 4132
MDL Number

MFCD00866001

Specifications
Appearance Colorless to Yellow clear liquid
Purity(HPLC) min. 98.0 area%
Purity(with Total Nitrogen) min. 98.0 %
NMR confirm to structure
Properties (reference)
Boiling Point 170 °C/1 mmHg
Flash point 192 °C
Specific Gravity (20/20) 1.21
Refractive Index 1.56
GHS
Pictogram Pictogram
Signal Word Warning
Hazard Statements H302 : Harmful if swallowed.
Precautionary Statements P501 : Dispose of contents/ container to an approved waste disposal plant.
P270 : Do not eat, drink or smoke when using this product.
P264 : Wash skin thoroughly after handling.
P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth.
Related Laws:
RTECS# DH8511000
Transport Information:
HS Number 2922500090
Application
Butyl Flufenamate: A Lipophilic Prodrug of Flufenamic Acid

Butyl flufenamate (ufenamate or HF-264) is a lipophilic prodrug of flufenamic acid [T2351]. It is reported that butyl flufenamate inhibits the synthesis of prostaglandin E1, but its inhibition is weaker than that of flufenamic acid. Its ointment is used topically for the treatment of eczema and atopic dermatitis in clinical use. (The product is for research purpose only.)

References


PubMed Literature


TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.